4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis

Details for Australian Patent Application No. 2008324243 (hide)

Owner Novartis AG

Inventors Mogi, Muneto; Iwaki, Yuki; Yasoshima, Kayo; Umemura, Ichiro; Yamada, Ken; Imase, Hidetomo; Kawanami, Toshio; Qin, Hongbo

Agent Davies Collison Cave

Pub. Number AU-B-2008324243

PCT Pub. Number WO2009/059943

Priority 60/985,456 05.11.07 US

Filing date 3 November 2008

Wipo publication date 14 May 2009

Acceptance publication date 8 March 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/5377 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/059943 Priority application(s): WO2009/059943

8 March 2012 Application Accepted

  Published as AU-B-2008324243

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324245-New carbohydrate derivatives

2008324242-A dispensing system for food products